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The central region of the colicin A polypeptide chain has been fused to the N-terminal part of ,&-lactamase 
through genetic recombination. This region comprising amino acid residues 70-335 confers on the hybrid 
protein the ability to protect sensitive cells from the lethal action of colicin A. Although colicin A belongs 
to the cytoplasmic compartment of E. coli, export of the hybrid protein to the periplasmic space was pro- 
moted by the signal peptide of /3-lactamase. 
Colicin Export Receptor Hybrid protein 
1. INTRODUCTION 
Colicin A is a channel-forming bactericidal pro- 
tein of Mr 63 000 [I]: it exerts its lethal effect on the 
E. coli sensitive cell through depolarization of the 
inner membrane and consequent dissipation of the 
cellular energy level [2]. The formation of the dissi- 
pative channel across the inner membrane follows 
binding of the colicin molecule to a specific recep- 
tor located in the outer membrane. This receptor is 
composed of two proteins: Omp F and Btu B [3,4]. 
The functions responsible for receptor binding and 
lethality have been located in different domains of 
the colicin polypeptides [5-81. The C-terminal 
domain of colicin A has been isolated and purified 
[9]. This polypeptide can produce channels in 
planar phospholipid bilayers [9] like colicin A [2] 
and thus is likely to be responsible for lethality. 
Furthermore, the complete nucleotide sequence of 
colicin A has been determined [l]. 
We demonstrate here that the domain of colicin 
A polypeptide chain responsible for receptor 
binding is located between amino acid residues 70 
Published by Elsevrer Science Publishers B. V. 
and 335 of the bacteriocin. This central domain of 
colicin A has been fused to the N-terminal part of 
,%lactamase through genetic recombination. 
Evidence is presented that export of the hybrid 
protein can be promoted by the signal peptide of 
P-lactamase. To our knowledge, this is the first 
demonstration that a significant part of a cytoplas- 
mic polypeptide chain can be expected to the peri- 
plasmic space. 
2. MATERIALS AND METHODS 
2.1. Materials 
Restriction endonucleases were purchased from 
Boehringer and Bethesda Research Laboratory. 
[32P]dATP and [3SS]methionine were obtained 
from Amersham. Mitomycin C was purchased 
from Sigma. 
2.2. Bacterial strains, plasmids 
E. coli K12 W3110, W3110 (ColA), RB113 and 
SK1592 (pBR322) have been described [lO,ll]. 
Cells were routinely grown in LB medium but 
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zl. Construction of the blu-caa hybrid gene. (A) The 
plasmid PVC 33, carrying b/a-caa hybrid gene, was con- 
structed by cloning the indicated Psi1 restriction frag- 
ment of CofA plasmid into the PstI site of the plasmid 
pBR322. (B) Reading frames and corresponding amino 
acid sequences around the PstI sites. The numbering of 
amino acids starts from the N-terminus of colicin A [l] 
and pm-&lactamase [ 181. 
otherwise stated, as in [ 111. The maxicell medium 
was as indicated by Sancar et al. (121. 
2.3. Y&.zxiceli ’ t~ch~i~~e, SDS gel e~ectr~~horesis, 
and l3N4 sequence analysts 
Proteins encoded by plasmids were detected as 
in 1121. 35S-labeled proteins were analyzed on 
SDS-polyacrylamide slab gels and fluorography 
was carried out as in [lo]. Nucleotide sequence 
analysis of recombined DNA was performed as in 
111. 
bla-cda junction: -- 
P* I 
bla-caa : GAG CGT ChC ACC ACG ATG C&T GCA* GGC CAG CCG ACC ATG AAC GGA -- 
CTC GCA ClG IGG 'KC TAC G&- ,,I .* I. . 7 ‘< CCG GTC GCC TGG TAC TTG CCT 
fusion 
protein : Glu Arg Asp Thr Thr Met Pro Ala Gly Gin Pro ‘rhr Met Asn Gky 
@-lacta- 
Illa se : Glu Arg Asp Thr Thr Met Pro Ala Ala klet Ala Thr Thr Leu Hrg -_------- 
182 
coli- 
tin A : Gly 1,~s Vai Kle Ile Asu Ala Ala Cly Gln Pro Thr Met Asn 9 ------- 
70 
caa-bla junction: -- p'st 1 - 
caa-bla : _- TCT CAG CCT AAT AAT ATC CTC C4c CAA 'KG CAA CA.4 CGT TGC GCA AAC TAT TAA 
AGA CTC: CGA TTA TTA TAG $IC GTC WI' ACC GTT GTT GCA ACG CGT TTG AX-A ATT 
fusion 
protein : Ser CLn Ala Asn Asn Lie Leu Cln Gln Trp Gin Cln Arg Cys Al~l As11 Tyr End 
coli- 
tin A : Ser Gin Ala Asn Asn Ile Leu Gin Am Ala Arg Am Glu Lys Ser Ala Ala .._------- 
335 
184 
Volume 172, number 2 FEBS LETTERS July 1984 
2.4. Immunoprecipitation region of the polypeptide chain was good. 
Antisera were prepared and imunoprecipitation 
was carried out as in [ 10,131. The antiserum directed 
against TEM-I &lactamase was a generous gift 
from G. Cesarini. All antisersa were preincubated 
with whole cells to remove eventual traces of anti- 
lipopolysaccharide antibodies. 
2.5. Preparation of subcellular fractions 
Cells were harvested by centrifugation and con- 
verted to spheroplasts as in [14]. The spheroplasts 
were centrifuged; the supernatant contained the 
periplasmic fraction. Spheroplasts were then resus- 
pended and lysed and cellular membranes were pel- 
leted by centrifugation; the supernatant contained 
the cytoplasmic fraction. Osmotic shock fluids 
were prepared as in [15]. 
A hybrid gene encoding the signal sequence of 
,&lactamase as well as the central part of colicin A 
polypeptide was constructed. A 0.9 kb PstI restric- 
tion fragment from ColA plasmid, containing half 
of the colicin A gene (caa) [1,17], was cloned into 
the unique PstI site of pBR322, in the &lactamase 
gene (fig.lA). This cloning does not alter the 
reading frame of the PstI restriction fragment of 
caa (fig.lB). It resulted in the formation of a 
hybrid bla-caa gene. The nucleotide sequence of 
the recombinant plasmid, named PVC 33, was 
checked at the junction region and found to corres- 
pond to that expected (fig.lB,2). 
2.6. Assay of cell survival in cell protection ex- 
perimen ts 
Binding of the hybrid protein to sensitive cells 
was assayed by measuring the degree of inhibition 
of bacteriocidal activity of native colicin A. A 
fixed amount of cells (5 x lO’/ml) was incubated 
with various amounts of the bacterial extract ob- 
tained after centrifugation of lyzed spheroplasts. 
The incubation was carried out for 5 min at 37°C 
and 1 ng/ml colicin A was then added. After a fur- 
ther incubation of 10 min at 37°C SDS (0.5 mg/ml) 
was added, and the incubation was continued for 
10 min. The absorbance of the cell suspension at 
600nm was then measured and the percentage of 
survival was calculated as in [16]. 
The hybrid protein produced has therefore the 
signal sequence and the N-terminal 158 amino acid 
residues of fl-lactamase [18], 266 amino acid resi- 
dues from colicin A [l] and 9 additional amino 
acid residues from the construction (before the 
first stop codon) (fig. 1B). This protein should have 
an M, of 50 791. It is under the control of the bla 
promoter and is thus rather weakly expressed. It 
could not be detected upon SDS-polyacrylamide 
gel electrophoresis of total cell proteins. There- 
fore, proteins encoded by PVC 33 were analyzed in 
the maxicell system [12]. A protein of about 
50 kDa was found to be synthesized (fig.3A, lane 
3). This protein was immunoprecipitated by anti- 
sera directed against either colicin A or ,&lact- 
amase which evidenced that the correct hybrid pro- 
tein was produced (fig.3B, lanes 5 and 7). 
3.2. Evidence for partial export of the hybrid 
protein 
3. RESULTS AND DISCUSSION 
3.1. Construction of hybrid gene (bla-caa) encod- 
ing the central region of colicin A polypeptide 
chain 
The complete nucleotide sequence of the struc- 
tural gene for colicin A has been determined [I]. 
Comparison of the deduced amino acid sequence 
with that of colicin El indicated that a homo- 
logous region extending over 10 amino acid resi- 
dues existed in the central part of the two colicins 
[l]. Since both proteins are known to interact with 
the BtuB protein and since the receptor binding 
domain has been located in this polypeptide region 
[6,8] for colicin El, the prospect of finding the 
receptor binding domain of colicin A in the central 
Since the hybrid protein comprised the signal se- 
quence of P-lactamase, its compartmentalization 
was checked. Cell fractionation showed that about 
50% of the hybrid protein was exported to the 
periplasmic space. Partial export was previously 
reported for ovalbumin 1191 and insulin [ZO] pro- 
duced in E. coli. The hybrid protein that remained 
in the cytoplasm was stable (fig.3B, lanes 5 and 7) 
whereas that transferred to the periplasmic space 
was cleaved by periplasmic proteases. A 26-kDa 
polypeptide, immunoprecipitated by anti-colicin A 
serum (fig.3B, lane 4) and a 2%kDa polypeptide 
immunoprecipitated by the anti-,&lactamase serum 
(fig.3B, lane 6) were found in the periplasmic 
fluid. Immunoprecipitation of the fusion frag- 
ments from the periplasmic space indicated that 
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Fig.2. Nucleotide sequence at the junction between bia 
and caa DNA fragments. The plasmid DNA was 
digested with CIaI (there are 2 Cla I sites, one in pBR322 
and one in caa) and labeled with f32PJdATP as in [ 11. 
The labeled DNA was cleaved with HincII and the 
343 bp ClaI/HincII fragment was purified and used for 
sequencing. Only the region around the Pstl site (indi- 
cated by an arrow) is shown. 
export had occurred. Cleavage of the Bla-Caa pro- 
tein occurred near the fusion joint. Indeed, a 
17.4-kDa fragment of fl-lactamase was contained 
in the hybrid protein and a 28-kDa fragment was 
immunoprecipitated by the anti-fl-lactamase serum 
from the periplasmic fluid (fig.3B, lane 6). How- 
ever, part of the chimeric polypeptide in its colicin 
A region appeared to be digested since a 26-kDa 
fragment instead of an expected 30-kDa one was im- 
munoprecipitated by anti-colicin A serum (fig.3B, 
lane 4). 
Colicin A is normally produced on free poly- 
l r 
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Fig.3. Expression and localization of the hybrid protein 
encoded by pVC33. (A) Expression of pVC33 in the 
maxicell system. Cells treated as in [ 121 were labeled for 
2 h in the presence of [ .“S] methionine and proteins were 
analyzed by SDS-polyacrylamide gel electrophoresis 
and fluorography. Lanes: (1) background control with 
RB113 cells, (2) RBI 13 (pBR322), (3) RB113 (pVC33), 
(4) RB113 (pColA). (B) Cell fractionation on W3110 
(pVC33) (lanes 2-7). Lanes: (1) the position of the 
hybrid protein RBl13 (pVC33), (2) total proteins from 
osmotic shock fluid; (3) total proteins from cytoplasmic 
compartment, immunoprecipitated proteins by the anti- 
colicin A serum, (4) from the periplasmic fluid and (5) 
from the cytoplasm, immunoprecipitated proteins by the 
anti-&lactamase serum, (6) from the periplasmic fluid 
and (7) from the cytoplasm. Arrows indicate the migra- 
tions of the native hybrid protein (b) and of the peri- 
plasmic degradation product immunoprecipitated by the 
anti-&lactamase serum (d). Calibrated proteins (a-f) 
have been described [I]. 
somes [21] and exclusively detected in the cyto- 
plasm of producing cells in electronmicroscopy 
[22]. A conclusion of this study is that part of the 
colicin A polypeptide can be directed to the peri- 
plasm by the signal sequence and the N-terminal 
region of ,8-lactamase. To our knowledge, a cyto- 
plasmic protein has never been directed to the peri- 
plasmic space in E. coli by genetic recombination. 
In particular, none of the protein fusions between 
alkaline phosphatase or the maltose-binding pro- 
tein and P-galactosidase has succeeded in transfer- 
ring this protein into this cell compartment [23]. 
The second conclusion of this work is that the 
,&lactamase-colicin A hybrid protein is unstable in 
the periplasmic space. The hybrid protein was 
probably cleaved around the fusion region but part 
of the colicin A polypeptide was also digested. 
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Fig.4 The hybrid protein contains the receptor-binding 
domain of calicin A. Cells sensitive to colicin A were 
pre-incubated with various amaunts of cytoplasmic 
proteins from W3110 (pVC31) (O---O) and W3110 
(pBR322) (e---o) and then with colicin A as indicated 
in section 2. The percentage of survival was pfotted as a 
function of the amount of cytoplasmic protein added. 
The concentration of colicin A was chosen such that 
about half of the cells was kiIIed in the absence of 
protection. 
lethal effects on sensitive cells but could protect 
these cells against the lethal action of colicin A. 
The protection of the cell pop~iation caused by the 
adsorbed hybrid protein was monitored through 
survival (fig.4). A given amount of colicin A that 
killed about 60% of the cells was used. The cells 
were either preincubated with growth medium or 
with a cytopiasmic extract containing the hybrid 
protein. Almost fuff protection of sensitive celfs 
could be obtained when sufficient extract was pro- 
vided. 
This result demonstrated that the region from 
amino acid residue 71 to 335 in the colicin A poly- 
peptide contained the receptor-binding domain, 
This region was correctly folded in the hybrid pro- 
tein since it coufd still bind the receptor located in 
the outer membrane. As previously reported regions 
234-243 of colicin El and 223-232 of colicin A are 
homoiogous f1]. Since both cohcins are supposed 
to interact with the Btu B protein and since the 
receptor-binding peptide in colicin El has been 
located between amino acid residues 230 and 370 
I8j it is tempting to speculate that the homologous 
peptides mentioned above are involved in Btu B 
binding. Site-directed mutagenesis experiments are 
pianned to test this hypothesis. 
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